» Articles » PMID: 35365075

Study Protocol: MyoFit46-the Cardiac Sub-study of the MRC National Survey of Health and Development

Abstract

Background: The life course accumulation of overt and subclinical myocardial dysfunction contributes to older age mortality, frailty, disability and loss of independence. The Medical Research Council National Survey of Health and Development (NSHD) is the world's longest running continued surveillance birth cohort providing a unique opportunity to understand life course determinants of myocardial dysfunction as part of MyoFit46-the cardiac sub-study of the NSHD.

Methods: We aim to recruit 550 NSHD participants of approximately 75 years+ to undertake high-density surface electrocardiographic imaging (ECGI) and stress perfusion cardiovascular magnetic resonance (CMR). Through comprehensive myocardial tissue characterization and 4-dimensional flow we hope to better understand the burden of clinical and subclinical cardiovascular disease. Supercomputers will be used to combine the multi-scale ECGI and CMR datasets per participant. Rarely available, prospectively collected whole-of-life data on exposures, traditional risk factors and multimorbidity will be studied to identify risk trajectories, critical change periods, mediators and cumulative impacts on the myocardium.

Discussion: By combining well curated, prospectively acquired longitudinal data of the NSHD with novel CMR-ECGI data and sharing these results and associated pipelines with the CMR community, MyoFit46 seeks to transform our understanding of how early, mid and later-life risk factor trajectories interact to determine the state of cardiovascular health in older age.

Trial Registration: Prospectively registered on ClinicalTrials.gov with trial ID: 19/LO/1774 Multimorbidity Life-Course Approach to Myocardial Health- A Cardiac Sub-Study of the MCRC National Survey of Health and Development (NSHD).

Citing Articles

Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.

Murray-Smith H, Barker S, Barkhof F, Barnes J, Brown T, Captur G BMC Neurol. 2024; 24(1):40.

PMID: 38263061 PMC: 10804658. DOI: 10.1186/s12883-023-03465-3.


Technical development and feasibility of a reusable vest to integrate cardiovascular magnetic resonance with electrocardiographic imaging.

Webber M, Joy G, Bennett J, Chan F, Falconer D, Shiwani H J Cardiovasc Magn Reson. 2023; 25(1):73.

PMID: 38044439 PMC: 10694972. DOI: 10.1186/s12968-023-00980-7.

References
1.
Santiago A, Aguado-Sierra J, Zavala-Ake M, Doste-Beltran R, Gomez S, Aris R . Fully coupled fluid-electro-mechanical model of the human heart for supercomputers. Int J Numer Method Biomed Eng. 2018; 34(12):e3140. DOI: 10.1002/cnm.3140. View

2.
Flett A, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C . Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011; 4(2):150-6. DOI: 10.1016/j.jcmg.2010.11.015. View

3.
Dass S, Suttie J, Piechnik S, Ferreira V, Holloway C, Banerjee R . Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging. 2012; 5(6):726-33. DOI: 10.1161/CIRCIMAGING.112.976738. View

4.
Augusto J, Davies R, Bhuva A, Knott K, Seraphim A, Alfarih M . Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance. Lancet Digit Health. 2021; 3(1):e20-e28. DOI: 10.1016/S2589-7500(20)30267-3. View

5.
Cavalcante J, Lima J, Redheuil A, Al-Mallah M . Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011; 57(14):1511-22. DOI: 10.1016/j.jacc.2010.12.017. View